<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9F19522C-49F3-4D2A-9018-7E4B0F4D8014"><gtr:id>9F19522C-49F3-4D2A-9018-7E4B0F4D8014</gtr:id><gtr:name>Division of Vector Borne Diseases</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9ABA0C2D-B8F1-4C2C-8B2A-A84BD534EEA7"><gtr:id>9ABA0C2D-B8F1-4C2C-8B2A-A84BD534EEA7</gtr:id><gtr:name>Maseno University</gtr:name><gtr:address><gtr:line1>Box 333-40105</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/96C5D993-E6CA-4E1C-9B98-BB8CEC9A4BFC"><gtr:id>96C5D993-E6CA-4E1C-9B98-BB8CEC9A4BFC</gtr:id><gtr:name>Pasteur Institute, Lille</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FC3C093C-F9CE-4465-95FD-3A43C57E7F1A"><gtr:id>FC3C093C-F9CE-4465-95FD-3A43C57E7F1A</gtr:id><gtr:name>Rigshospitalet</gtr:name><gtr:address><gtr:line1>Blegdamsvej 9</gtr:line1><gtr:region>outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DBEA9B4D-7F8B-4D64-84B2-7F8F585EDD3D"><gtr:id>DBEA9B4D-7F8B-4D64-84B2-7F8F585EDD3D</gtr:id><gtr:name>National Institute of Allergy and Infectious Diseases (NIAID)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/82200E1A-04DA-42F5-80F3-B0FF026643BD"><gtr:id>82200E1A-04DA-42F5-80F3-B0FF026643BD</gtr:id><gtr:name>University of Copenhagen</gtr:name><gtr:address><gtr:line1>Norregade 10</gtr:line1><gtr:line2>Postboks 2177</gtr:line2><gtr:line4>Copenhagen K</gtr:line4><gtr:line5>DK-1017</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Denmark</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3C980328-0218-4907-B784-9CAB61235313"><gtr:id>3C980328-0218-4907-B784-9CAB61235313</gtr:id><gtr:name>Ministry of Health, Uganda</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A861D5B4-C006-49D3-8DF9-5C184B00E4AC"><gtr:id>A861D5B4-C006-49D3-8DF9-5C184B00E4AC</gtr:id><gtr:name>Kenyan Institute for Medical Research (KEMRI)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/19A2A787-2FDB-4397-9885-403B7C582232"><gtr:id>19A2A787-2FDB-4397-9885-403B7C582232</gtr:id><gtr:name>Leiden University Medical Center</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/ACCAA472-353D-4CD6-814A-04677AE5E921"><gtr:id>ACCAA472-353D-4CD6-814A-04677AE5E921</gtr:id><gtr:name>MRC/UVRI Uganda Research Unit on AIDS</gtr:name><gtr:address><gtr:line1>Uganda Virus Research Institute</gtr:line1><gtr:line2>51-59 Nakiwogo Road, PO box 49</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Uganda</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9F19522C-49F3-4D2A-9018-7E4B0F4D8014"><gtr:id>9F19522C-49F3-4D2A-9018-7E4B0F4D8014</gtr:id><gtr:name>Division of Vector Borne Diseases</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9ABA0C2D-B8F1-4C2C-8B2A-A84BD534EEA7"><gtr:id>9ABA0C2D-B8F1-4C2C-8B2A-A84BD534EEA7</gtr:id><gtr:name>Maseno University</gtr:name><gtr:address><gtr:line1>Box 333-40105</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/96C5D993-E6CA-4E1C-9B98-BB8CEC9A4BFC"><gtr:id>96C5D993-E6CA-4E1C-9B98-BB8CEC9A4BFC</gtr:id><gtr:name>Pasteur Institute, Lille</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FC3C093C-F9CE-4465-95FD-3A43C57E7F1A"><gtr:id>FC3C093C-F9CE-4465-95FD-3A43C57E7F1A</gtr:id><gtr:name>Rigshospitalet</gtr:name><gtr:address><gtr:line1>Blegdamsvej 9</gtr:line1><gtr:region>outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DBEA9B4D-7F8B-4D64-84B2-7F8F585EDD3D"><gtr:id>DBEA9B4D-7F8B-4D64-84B2-7F8F585EDD3D</gtr:id><gtr:name>National Institute of Allergy and Infectious Diseases (NIAID)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/82200E1A-04DA-42F5-80F3-B0FF026643BD"><gtr:id>82200E1A-04DA-42F5-80F3-B0FF026643BD</gtr:id><gtr:name>University of Copenhagen</gtr:name><gtr:address><gtr:line1>Norregade 10</gtr:line1><gtr:line2>Postboks 2177</gtr:line2><gtr:line4>Copenhagen K</gtr:line4><gtr:line5>DK-1017</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Denmark</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3C980328-0218-4907-B784-9CAB61235313"><gtr:id>3C980328-0218-4907-B784-9CAB61235313</gtr:id><gtr:name>Ministry of Health, Uganda</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A861D5B4-C006-49D3-8DF9-5C184B00E4AC"><gtr:id>A861D5B4-C006-49D3-8DF9-5C184B00E4AC</gtr:id><gtr:name>Kenyan Institute for Medical Research (KEMRI)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/19A2A787-2FDB-4397-9885-403B7C582232"><gtr:id>19A2A787-2FDB-4397-9885-403B7C582232</gtr:id><gtr:name>Leiden University Medical Center</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/ACCAA472-353D-4CD6-814A-04677AE5E921"><gtr:id>ACCAA472-353D-4CD6-814A-04677AE5E921</gtr:id><gtr:name>MRC/UVRI Uganda Research Unit on AIDS</gtr:name><gtr:address><gtr:line1>Uganda Virus Research Institute</gtr:line1><gtr:line2>51-59 Nakiwogo Road, PO box 49</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Uganda</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/350826B5-792C-403C-889D-C0CEEDD4EA71"><gtr:id>350826B5-792C-403C-889D-C0CEEDD4EA71</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>William</gtr:otherNames><gtr:surname>Dunne</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G7708609"><gtr:id>008CB365-DEAB-4F01-899F-B6017AE95F44</gtr:id><gtr:title>Immunology of human schistosomiasis: immunity, disease and co-infections</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G7708609</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2006-05-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1979-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>3653166</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leeds</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Drs MA. Shaw, R. Quinnell (University of Leeds)</gtr:description><gtr:id>56F07932-FFDA-493F-8D3D-E4A36A73A573</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>DgkFKsTQCHx-1</gtr:outcomeId><gtr:partnerContribution>University of Leeds, Leeds, UK: Drs MA. Shaw, R. Quinnell, collaboration in studies on HLA associations with IgE responses and immunity in human schistosomiasis.</gtr:partnerContribution><gtr:piContribution>NA</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute of Allergy and Infectious Diseases (NIAID)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Dr TA. Wynn (NIAID)</gtr:description><gtr:id>A0E0897F-E970-45EE-A81F-36B694D81F70</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>qpnaZwxTKeS-1</gtr:outcomeId><gtr:partnerContribution>National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, USA: Dr TA. Wynn, collaboration on the possible immunoregulatory role of the IL-13alpha-2 'decoy' receptor in human schistosomiasis.</gtr:partnerContribution><gtr:piContribution>NA</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Kenyan Institute for Medical Research (KEMRI)</gtr:collaboratingOrganisation><gtr:country>Kenya, Republic of</gtr:country><gtr:description>Drs. G. Kimani, JK. Mwatha (Kenyan Medical Research Institute)</gtr:description><gtr:id>F68CDE75-FF9A-4B69-B6DC-D0E32AD63CA6</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>rBMc9rWjkW1-1</gtr:outcomeId><gtr:partnerContribution>provided field immunology, ultrasonography, and field laboratory support in both Kenya and Uganda</gtr:partnerContribution><gtr:piContribution>NA</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Professor A. Fenwick, Dr. NB. Kabatereine (National Schistosomiasis Control Programme)</gtr:description><gtr:id>FD52FB18-8CC7-4BDF-B340-AE8D3484FDC7</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>s866hYeVk4B-1</gtr:outcomeId><gtr:partnerContribution>Schistosomiasis Control Initiative, Imperial College, London, UK. Gates Foundation Uganda National Schistosomiasis Control Programme: Professor A. Fenwick, Dr. NB. Kabatereine, we provided training for Ugandan national control programme personnel in clinical and ultrasonography techniques for evaluating schistosomiasis morbidity and close cooperation between research project and control programme in Uganda ensured the success of complimentary research and control activities.</gtr:partnerContribution><gtr:piContribution>NA</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Rigshospitalet</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:description>Professor Per Skov (The Danish National University Hospital)</gtr:description><gtr:id>121ECD22-3A94-402E-9002-C8EC254D02CB</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>rTwYXh9ZmdM-1</gtr:outcomeId><gtr:partnerContribution>The Danish National University Hospital, Copenhagen, Denmark: Professor Per Skov: collaboration in all aspects of studies on the interactions between IgE-mediated basophil function and human schistosomiasis.</gtr:partnerContribution><gtr:piContribution>NA</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>London School of Hygiene and Tropical Medicine (LSHTM)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Dr RA Sturrock (LSHTM)</gtr:description><gtr:id>7222B31D-EC13-4692-87CF-B9639347EF50</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>EBrRKV2aMFf-1</gtr:outcomeId><gtr:partnerContribution>London School of Hygiene and Tropical Medicine: Dr RA Sturrock, provided external quality control of parasitology teams in Kenya and Uganda.</gtr:partnerContribution><gtr:piContribution>NA</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pasteur Institute, Lille</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Dr J. Khalife (Insitute Pasteur)</gtr:description><gtr:id>065624F7-2900-497A-8DAF-C52EAA781766</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>bghFzhFeT2c-1</gtr:outcomeId><gtr:partnerContribution>Institut Pasteur de Lille, Lille, France: Dr J. Khalife, collaboration on the identification of cross-reactive malaria/schistosome Ags.</gtr:partnerContribution><gtr:piContribution>NA</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Leiden University Medical Center</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Dr CH. Hokke, Dr M. Weiner, Prof AM. Deelder (Leiden)</gtr:description><gtr:id>3A0809E2-EDFD-4E43-9077-33C89AC80D42</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>pXERLYWd3jG-1</gtr:outcomeId><gtr:partnerContribution>Leiden University Medical Center, Leiden, Netherlands: Dr CH. Hokke, Dr M. Weiner, Prof AM. Deelder, collaborative studies on the structure and glycosylation of S. mansoni antigens; Prof M. Yazdanbakhsh, collaboration on human antibody responses to S. haematobium Ags.</gtr:partnerContribution><gtr:piContribution>NA</gtr:piContribution><gtr:sector>Multiple</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Maseno University</gtr:collaboratingOrganisation><gtr:country>Kenya, Republic of</gtr:country><gtr:description>Professor JH. Ouma (University of Maseno, Kisumu, Kenya)</gtr:description><gtr:id>090EFCAD-54BD-430C-96C0-1209C7797AFA</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>BfaKPtKsAyU-1</gtr:outcomeId><gtr:partnerContribution>provided field management support for vector and field studies in Kenya and Uganda</gtr:partnerContribution><gtr:piContribution>NA</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>MRC/UVRI Uganda Research Unit on AIDS</gtr:collaboratingOrganisation><gtr:country>Uganda, Republic of</gtr:country><gtr:description>Dr A. Elliott and Dr. M. Brown (Uganda Institute of Virus Research and the MRC HIV Unit)</gtr:description><gtr:id>DCA65AC5-4245-4E97-A675-7789C46831D8</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>cxJNTkNi5h9-1</gtr:outcomeId><gtr:partnerContribution>Dr A. Elliott and Dr. M. Brown collaborated on studies on interactions between schistosomiasis, helminths and HIV infections.</gtr:partnerContribution><gtr:piContribution>NA</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Division of Vector Borne Diseases</gtr:collaboratingOrganisation><gtr:country>Kenya, Republic of</gtr:country><gtr:description>Drs E. Mucheri, HC Kariuki (Kenyan Ministry of Health)</gtr:description><gtr:id>91F89922-6E20-46E0-9072-D62C3D484DE3</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>JqA9UF2CXTp-1</gtr:outcomeId><gtr:partnerContribution>provided demonography, epidemiology, malocology, and entomology support in both Kenya and Uganda</gtr:partnerContribution><gtr:piContribution>NA</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ministry of Health, Uganda</gtr:collaboratingOrganisation><gtr:country>Uganda, Republic of</gtr:country><gtr:description>Dr NB. Kabatereine, Dr F. Kazibwe (Ugandan Ministry of Health)</gtr:description><gtr:id>C37AAB81-72DD-4CC0-9C1B-A9E23D8B910C</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>i9QA2cWmNaC-1</gtr:outcomeId><gtr:partnerContribution>contributed field workers/management, demonography, vector studies, community health coverage, parasitological screening, and to all aspects of community work in Uganda</gtr:partnerContribution><gtr:piContribution>NA</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Copenhagen</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:department>DBL - Centre for Health Research and Development</gtr:department><gtr:description>Dr BJ. Vennervald (Institute for Health Research and Development, Charlottenlund, Denmark)</gtr:description><gtr:id>536AD767-CFDC-4162-8CC9-3503D0980F2C</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>PyoHtCtUj5b-1</gtr:outcomeId><gtr:partnerContribution>collaboration on clinical, ultrasonography, training aspects, plus additional logistic support for African partners; Dr CM. Reimert, collaboration in eosinophil studies</gtr:partnerContribution><gtr:piContribution>NA</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>invited talks to KS2 and KS3 pupils at Lady Adrian School, Cambridge</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>18AF096E-EE2C-4636-A4EC-B0F5047A4C34</gtr:id><gtr:impact>January 2006 invited talks to KS2 and KS3 pupils at Lady Adrian School, Cambridge, about the Matangini Project.

NA</gtr:impact><gtr:outcomeId>Gp2fgFt1trY</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>175714</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MUSTSchistUKEMA FP6 Follow on funding (1.5m euros across 7 participants)</gtr:description><gtr:end>2009-08-02</gtr:end><gtr:fundingOrg>Sixth Framework Programme (FP6)</gtr:fundingOrg><gtr:id>58559E11-D119-4D66-94A0-BFA82F92FFFE</gtr:id><gtr:outcomeId>q2ofFDyf99U0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2005-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:description>Clinical and ultrasonographic examination methods that we devised to assess schistosomiasis hepatosplenic morbidity, in the present or absence of gross hepatic periportal fibrosis have be transferred to Ugandan National Schistosomiasis Control Programme staff and onwards to other sub-Saharan African countries that have initiated National Control Programmes with funding from the Bill and Melinda Gates 'Schistosomiasis Control Initiative, including Tanzania, Mali, Zambia.</gtr:description><gtr:id>9F599F40-EB68-4D3E-9CBB-0F82005D89CD</gtr:id><gtr:impact>Schistosomiasis mansoni is a serious public health problem in Uganda, with high transmission and severe morbidity. In addition to generating unique longitudinal data on the morbidity of, and immunity to, schistosomiasis, this programme provided data and training, which increased Ugandan operational capacity. The main Uganda parasitic disease control agency, the Ministry of Health's Vector Control Division (VCD), was moribund until 1994, when African Development Bank aid provided funds for its rehabilitation. Our collaborative studies with the Danish Bilharziasis Laboratory (DBL) and, in South-South collaboration, with the Ministry of Health of neighbouring Kenya, through it's Division of Vector Borne Diseases (DVBD) and Kenya Medical Research Institute (KEMRI) helped rebuild VCD's capacity in applied research and control. This was also facilitated by successive EC grants, which we coordinated between 1996 and 2004 that gave added value to MRC funding, and re-vitalization VCD to the point where it could be the first African partner in the Gates Foundation's Schistosomiasis Control Initiative (SCI) in sub-Saharan Africa, launched in Uganda March 2003. In the order of 3 million doses of PZQ have administered by SCI in the last 3 years, using the treatment regimen reported to be safe and effective in community-wide treatments in Piida and Booma. The clinical and ultrasonography methods being used to evaluate the efficacy of the control programme were devised and evaluated in our programme, and Kenyan and Ugandan colleagues have trained SCI staff in suitably modified methods for mass use. Our Ugandan and Kenyan staff have subsequently be involved in training technicians and nurses in other SCI target countries, including in Tanzania, Zambia, Mali and elsewhere.</gtr:impact><gtr:outcomeId>pAunPx1bFyH</gtr:outcomeId><gtr:stage>Small-scale adoption</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Schistosomiasis hepatosplenic morbidity assessment</gtr:title><gtr:type>Diagnostic Tool - Imaging</gtr:type><gtr:yearDevCompleted>2006</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>69C2C900-AB1F-4DCE-B3A6-DF6E82962BF2</gtr:id><gtr:title>Identification of a novel antigen of Schistosoma mansoni shared with Plasmodium falciparum and evaluation of different cross-reactive antibody subclasses induced by human schistosomiasis and malaria.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4899065560090bf5b1075609b8a54e94"><gtr:id>4899065560090bf5b1075609b8a54e94</gtr:id><gtr:otherNames>Pierrot C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>Y5m2WDJNUjA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>26B8CBB3-3A2F-4B24-AFF2-3F42E053CD84</gtr:id><gtr:title>Carriage of DRB1*13 is associated with increased posttreatment IgE levels against Schistosoma mansoni antigens and lower long-term reinfection levels.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebccfe7208e85c1c483f80303f097a8d"><gtr:id>ebccfe7208e85c1c483f80303f097a8d</gtr:id><gtr:otherNames>Booth M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>585d4f1778fe34.77534638</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A94834CF-8C58-4048-B749-C258CF307A3C</gtr:id><gtr:title>IPSE/alpha-1, a major secretory glycoprotein antigen from schistosome eggs, expresses the Lewis X motif on core-difucosylated N-glycans.</gtr:title><gtr:parentPublicationTitle>The FEBS journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/498dbc62f8e7e31c784ed591ed9c47c3"><gtr:id>498dbc62f8e7e31c784ed591ed9c47c3</gtr:id><gtr:otherNames>Wuhrer M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>aL8PoWB48Jc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FBB6A7BD-5B5B-4869-8325-5C254E7B6840</gtr:id><gtr:title>Eosinophil activity in Schistosoma mansoni infections in vivo and in vitro in relation to plasma cytokine profile pre- and posttreatment with praziquantel.</gtr:title><gtr:parentPublicationTitle>Clinical and vaccine immunology : CVI</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/742e6bff4453212e394e24833f1366cf"><gtr:id>742e6bff4453212e394e24833f1366cf</gtr:id><gtr:otherNames>Reimert CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1556-679X</gtr:issn><gtr:outcomeId>Th89e6Q7HU5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38E20EC0-8C05-4094-B0AB-FB0CDF836782</gtr:id><gtr:title>Changes in IgE- and antigen-dependent histamine-release in peripheral blood of Schistosoma mansoni-infected Ugandan fishermen after treatment with praziquantel.</gtr:title><gtr:parentPublicationTitle>BMC immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c502638ba9ebf75b7d643e2dfb0293b2"><gtr:id>c502638ba9ebf75b7d643e2dfb0293b2</gtr:id><gtr:otherNames>Satti MZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>1471-2172</gtr:issn><gtr:outcomeId>pm_16218_18_15102330</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>629BC49D-3385-4D0A-A3F1-909F983E8F05</gtr:id><gtr:title>Impairment of the Schistosoma mansoni-specific immune responses elicited by treatment with praziquantel in Ugandans with HIV-1 coinfection.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c886ea6a1f8c575a3e82ba71366caa9"><gtr:id>7c886ea6a1f8c575a3e82ba71366caa9</gtr:id><gtr:otherNames>Joseph S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>pm_16218_18_15243939</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>466AF709-6F0B-4465-95DD-C334CB89C90F</gtr:id><gtr:title>Increased human IgE induced by killing Schistosoma mansoni in vivo is associated with pretreatment Th2 cytokine responsiveness to worm antigens.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0cbffca70f2259e2aba7f6199e0e96a7"><gtr:id>0cbffca70f2259e2aba7f6199e0e96a7</gtr:id><gtr:otherNames>Walter K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>585d4f1c34ec63.76303310</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6339673-393A-4D10-97B4-A37883A376C9</gtr:id><gtr:title>Applied and basic research on the epidemiology, morbidity, and immunology of schistosomiasis in fishing communities on Lake Albert, Uganda.</gtr:title><gtr:parentPublicationTitle>Transactions of the Royal Society of Tropical Medicine and Hygiene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5648dfe5311a76db6768a03a0c6bd220"><gtr:id>5648dfe5311a76db6768a03a0c6bd220</gtr:id><gtr:otherNames>Dunne DW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0035-9203</gtr:issn><gtr:outcomeId>cBtdSVAhPt7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42D3651C-A5D7-49B2-82B1-E5DD860013B4</gtr:id><gtr:title>Schistosoma mansoni, nematode infections, and progression to active tuberculosis among HIV-1-infected Ugandans.</gtr:title><gtr:parentPublicationTitle>The American journal of tropical medicine and hygiene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2df6cf0e44bda3035674f81d473ebf19"><gtr:id>2df6cf0e44bda3035674f81d473ebf19</gtr:id><gtr:otherNames>Brown M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0002-9637</gtr:issn><gtr:outcomeId>BJ8QxqcNTsG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9D5F28D-81A8-496A-B698-039CA9898ACC</gtr:id><gtr:title>Characterization of immunoglobulin binding by schistosomes.</gtr:title><gtr:parentPublicationTitle>Parasite immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d24fdfc9e9f243d120e2a20a9f7b7f8"><gtr:id>4d24fdfc9e9f243d120e2a20a9f7b7f8</gtr:id><gtr:otherNames>McIntosh RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0141-9838</gtr:issn><gtr:outcomeId>LEkNNkDyJZ3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D972010-D6BC-43BF-9CCA-04ED912EBA40</gtr:id><gtr:title>Human IgE response to the Schistosoma haematobium 22.6 kDa antigen.</gtr:title><gtr:parentPublicationTitle>Parasite immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/687a2ffe0fc69ab4afa58483d61b6a0a"><gtr:id>687a2ffe0fc69ab4afa58483d61b6a0a</gtr:id><gtr:otherNames>Fitzsimmons CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0141-9838</gtr:issn><gtr:outcomeId>pm_16218_18_15679635</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>33CF3FF9-B733-4C62-AA93-BF509B447F86</gtr:id><gtr:title>Hepatosplenic morbidity in two neighbouring communities in Uganda with high levels of Schistosoma mansoni infection but very different durations of residence.</gtr:title><gtr:parentPublicationTitle>Transactions of the Royal Society of Tropical Medicine and Hygiene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebccfe7208e85c1c483f80303f097a8d"><gtr:id>ebccfe7208e85c1c483f80303f097a8d</gtr:id><gtr:otherNames>Booth M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0035-9203</gtr:issn><gtr:outcomeId>pm_16218_18_14964813</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25173AB2-3FC3-4AE9-80CF-8DE73B7D793D</gtr:id><gtr:title>Human eosinophils modulate peripheral blood mononuclear cell response to Schistosoma mansoni adult worm antigen in&amp;nbsp;vitro.</gtr:title><gtr:parentPublicationTitle>Parasite immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c49dd8cd31478ca89c8f8649d7f6a097"><gtr:id>c49dd8cd31478ca89c8f8649d7f6a097</gtr:id><gtr:otherNames>Tweyongyere R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0141-9838</gtr:issn><gtr:outcomeId>5a616393949326.27922421</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9CDCD5E9-2EE9-4196-BB7B-1C4ECEEE6372</gtr:id><gtr:title>Chemotherapy for schistosomiasis in Ugandan fishermen: treatment can cause a rapid increase in interleukin-5 levels in plasma but decreased levels of eosinophilia and worm-specific immunoglobulin E.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/687a2ffe0fc69ab4afa58483d61b6a0a"><gtr:id>687a2ffe0fc69ab4afa58483d61b6a0a</gtr:id><gtr:otherNames>Fitzsimmons CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>pm_16218_18_15213147</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>482C6319-3933-40B0-ABE8-2A759D316230</gtr:id><gtr:title>Factors affecting human IgE and IgG responses to allergen-like Schistosoma mansoni antigens: Molecular structure and patterns of in vivo exposure.</gtr:title><gtr:parentPublicationTitle>International archives of allergy and immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/687a2ffe0fc69ab4afa58483d61b6a0a"><gtr:id>687a2ffe0fc69ab4afa58483d61b6a0a</gtr:id><gtr:otherNames>Fitzsimmons CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1018-2438</gtr:issn><gtr:outcomeId>rvfZrkMUR5m</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G7708609</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>